| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.49B | 5.82B | 5.84B | 5.90B | 5.36B | 4.02B |
| Gross Profit | 1.62B | 1.60B | 1.59B | 1.55B | 1.55B | 1.10B |
| EBITDA | 857.23M | 798.86M | 902.67M | 869.72M | 945.11M | 656.43M |
| Net Income | 343.09M | 350.09M | 484.12M | 532.24M | 625.51M | 343.67M |
Balance Sheet | ||||||
| Total Assets | 12.61B | 11.91B | 10.91B | 8.54B | 7.60B | 5.48B |
| Cash, Cash Equivalents and Short-Term Investments | 1.71B | 1.67B | 2.38B | 823.00M | 735.54M | 665.16M |
| Total Debt | 3.36B | 2.22B | 1.87B | 1.65B | 1.11B | 1.20B |
| Total Liabilities | 8.43B | 7.80B | 6.89B | 4.68B | 3.90B | 3.02B |
| Stockholders Equity | 2.05B | 1.99B | 1.92B | 3.86B | 3.70B | 2.46B |
Cash Flow | ||||||
| Free Cash Flow | -632.03M | -913.15M | -424.63M | -377.10M | -388.91M | 473.42M |
| Operating Cash Flow | 147.74M | -224.81M | 65.94M | 176.38M | 280.95M | 761.81M |
| Investing Cash Flow | -967.22M | -828.22M | -505.10M | -547.39M | -608.64M | -240.78M |
| Financing Cash Flow | 563.74M | 250.98M | 2.23B | 502.53M | 396.24M | -706.03M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$16.38B | 12.66 | 13.39% | 3.23% | 2.87% | 17.03% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | HK$1.05B | 4.73 | 4.79% | 7.16% | 17.21% | 29.75% | |
60 Neutral | HK$4.00B | 11.70 | 17.97% | 2.25% | 14.32% | -19.44% | |
58 Neutral | HK$10.10B | 7.99 | 8.82% | 2.50% | 11.18% | 46.57% | |
45 Neutral | HK$3.19B | -3.37 | -69.18% | ― | -4.88% | -860.80% | |
41 Neutral | HK$6.37B | -38.12 | -5.68% | ― | 7.11% | 77.53% |